NasdaqGS - Nasdaq Real Time Price • USD
Akero Therapeutics, Inc. (AKRO)
At close: May 31 at 4:00 PM EDT
All SEC Filings
Corporate Changes & Voting Matters
Periodic Financial Reports
Proxy Statements
Tender Offer/Acquisition Reports
Offering Registrations
Performance Overview
Trailing total returns as of 5/31/2024, which may include dividends or other distributions. Benchmark is S&P 500
Return | AKRO | S&P 500 |
---|---|---|
YTD | -19.31% | +10.64% |
1-Year | -57.07% | +25.49% |
3-Year | -28.04% | +25.53% |